Cancer clinical trials in the region Pays de la Loire

174 currently recruiting clinical trials
Region Pays de la Loire

Phase 3 Breast cancer
#NCT05232916
HER2 Positive Localized Locally Advanced Targeted therapy Targeted therapy
Systemic Treatment-Naive Systemic Treatment-Naive
10 main criterias to confirm
Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire)
Greenwich LifeSciences, Inc.
Phase 3 Breast cancer
#NCT06312176
HER2 Negative HR Positive Locally Advanced Metastatic Targeted therapy Hormone therapy
Chemotherapy
8 main criterias to confirm
Hôpital Privé du Confluent - Vivalto Santé (Nantes)
Merck Sharp & Dohme LLC
Phase 3 Prostate cancer
#NCT06120491
Metastatic Hormone-sensitive Other mutation Surgery Radiotherapy
8 main criterias to confirm
CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Régional Universitaire de Tours (Tours)
AstraZeneca
Phase 3 Lymphoma
#NCT05100862
B cell lymphoma Follicular lymphoma Marginal zone lymphoma Targeted therapy 1 2 3 or more
6 main criterias to confirm
Centre Hospitalier du Mans (Le Mans)
BeiGene
Phase 3 Liver and bile duct cancer
#NCT05301842
Hepatocellular carcinoma Localized Locally Advanced Unhealthy A
8 main criterias to confirm
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire Angers (Angers )
AstraZeneca
Phase 3 Liver and bile duct cancer
#NCT05078047
Hepatocellular carcinoma Metastatic Immunotherapy
6 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Eugene Marquis (Rennes), Centre Hospitalier Régional Universitaire de Tours (Tours), Clinique Mutualiste de l'Estuaire HGO - Ramsay Santé (Saint-Nazaire)
UNICANCER
Phase 3 Liver and bile duct cancer
#NCT05883644
Hepatocellular carcinoma Locally Advanced Systemic Treatment-Naive Unhealthy A B B C
Radiotherapy
11 main criterias to confirm
CHU de Rennes - Hôpital Pontchaillou (Rennes)
AstraZeneca
Phase 3 Liver and bile duct cancer
#NCT05876754
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic IDH1/2
Transplant Systemic Treatment-Naive
7 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes)
Servier
Phase 3 Prostate cancer
#NCT05939414
Biochemical recurrence Metastatic Hormone-sensitive Surgery Radiotherapy PSMA PET Positive
6 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Novartis
Phase 3 Breast cancer
#NCT06016738
HER2 Negative HR Positive Locally Advanced Metastatic Targeted therapy Hormone therapy
Chemotherapy
8 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier du Mans (Le Mans)
Olema Pharmaceuticals, Inc.